Inventor · disambiguated record
Dieter Willbold
Also filed as: WILLBOLD DIETER
20 granted patents·15 pending applications·22 citations·filing 2004–2022
91Inventor score
Top patents by PatentIndex Score
35 records- 0180US10123530B2Method for treating blood, blood products and organsFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2017·Granted Nov 13, 2018·2 cites·14 claims
- 0279US9591845B2Method for treating blood, blood products and organsFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Granted Mar 14, 2017·3 cites·15 claims
- 0378US9464118B2Polymers containing multivalent amyloid-beta-binding D-peptides and their useFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Granted Oct 11, 2016·5 cites·18 claims
- 0476US10239923B2Specific amyloid beta binding peptides and the use of same for treating and diagnosing alzheimer's dementiaFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2016·Granted Mar 26, 2019·3 cites·15 claims
- 0572US10995118B2Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's diseaseFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted May 4, 2021·1 cites·1 claims
- 0672US10428127B2Cyclic, amyloid beta-binding peptides and the use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted Oct 1, 2019·1 cites·18 claims
- 0772US9051364B2Composition for producing anti-amyloid beta peptide antibodies with D-peptidesWILLBOLD DIETER·Filed 2009·Granted Jun 9, 2015·4 cites·8 claims
- 0871US10167318B2D-enantiomeric peptides derived from D3 and use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2017·Granted Jan 1, 2019·1 cites·20 claims
- 0967US10889618B2D-enantiomeric peptides derived from D3 and use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2018·Granted Jan 12, 2021·0 cites·18 claims
- 1067US10772321B2Method for treating blood, blood products and organsFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2018·Granted Sep 15, 2020·0 cites·14 claims
- 1166US11274125B2Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of Alzheimer's diseaseFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2020·Granted Mar 15, 2022·0 cites·8 claims
- 1264US10174097B2Specific A-beta species-binding peptides for the therapy and/or diagnosis of Alzheimer's dementiaFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2016·Granted Jan 8, 2019·1 cites·10 claims
- 1359US2025346629A1Use of d-enantiomeric peptide ligands of monomeric alpha-synuclein for the therapy of various synucleinopathiesPRIAVOID GMBH·Filed 2022·Application pending·0 cites
- 1459US2025326795A1Use of d-enantiomeric peptide ligands of monomeric tau for the therapy of various tauopathiesPRIAVOID GMBH·Filed 2022·Application pending·0 cites
- 1557US11175288B2Method for detecting indicators for determining diseasesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted Nov 16, 2021·1 cites·10 claims
- 1654US9580469B2Peptides for the treatment and early diagnosis of Alzheimer's disease and other tauopathiesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Granted Feb 28, 2017·0 cites·10 claims
- 1751US2015307552A1Novel d-enantiomeric peptides derived from d3 and use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Application pending·0 cites
- 1848US2023228771A1Determination of disease-specific protein aggregates in stool samplesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2021·Application pending·0 cites
- 1944US10746747B2Method for quantitative characterization of substances with regard to their properties of binding to amyloid-β (Aβ) conformersFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted Aug 18, 2020·0 cites·12 claims
- 2044US10088487B2Method for the quantitative characterization of amyloid and/or aggregating peptides and/or proteins in a sampleFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted Oct 2, 2018·0 cites·19 claims
- 2144US2015037826A1Standard for quantifying pathogenic aggregates from proteins produced naturally in the bodyFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2012·Application pending·0 cites
- 2243US2021302418A1Ultrasensitive detection of virus particles and virus-like particlesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2017·Application pending·0 cites
- 2343US2023221309A1Method, use of the method and kit for detecting bioindicators in a sampleFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2021·Application pending·0 cites
- 2441US2021087232A1D-enantiomeric peptides for anti-inflammatory treatment of amyotropic lateral sclerosis (als) and other diseases driven by neuro-inflammationFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2019·Application pending·0 cites
- 2541US2016376335A1Polymers containing multivalent amyloid-beta-binding d-peptides and their useFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2016·Application pending·0 cites
- 2640US11224632B2Methods of treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptidesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2017·Granted Jan 18, 2022·0 cites·16 claims
- 2740US9611296B2Peptides that bind to amino-truncated amyloid-beta-peptide and use of said peptidesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Granted Apr 4, 2017·0 cites·16 claims
- 2840US2006281676A1Agent and method for the treatment and prevention of tse and method for the production of said agentWILLBOLD DIETER·Filed 2004·Application pending·0 cites
- 2938US2013143822A1Agents for treating alzheimer's diseaseFUNKE SUSANNE AILEEN·Filed 2011·Application pending·0 cites
- 3037US2020319208A1Method for quantifying protein aggregates of a protein misfolding disease in a sampleFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2018·Application pending·0 cites
- 3136US10030056B2Agents for preventing and treating HIV and other viral infectionsFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted Jul 24, 2018·0 cites·13 claims
- 3236US2015024512A1Method for selectively quantifying a-beta aggregatesFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2012·Application pending·0 cites
- 3334US10948499B2Method for producing a standard for detecting protein aggregates of a protein misfolding disease, standard and use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2016·Granted Mar 16, 2021·0 cites·1 claims
- 3434US2020200740A1Method for detecting extracellular vesicles in a sampleFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2018·Application pending·0 cites
- 3534US2020200748A1Method for detecting aggregates of biotherapeutic substances in a sampleFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dieter Willbold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →